C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 7/00 (2006.01) A61K 38/00 (2006.01) A61K 38/08 (2006.01) A61K 51/00 (2006.01) A61P 1/02 (2006.01) A61P 1/04 (2006.01) A61P 9/00 (2006.01) A61P 9/10 (2006.01) A61P 15/08 (2006.01) A61P 17/06 (2006.01) A61P 17/12 (2006.01) A61P 19/02 (2006.01) A61P 27/02 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) C07K 14/00 (2006.01)
Patent
CA 2420577
This invention relates to new peptide-based compounds and their use in therapeutically effective treatments as well as for diagnostic imaging techniques. More specifically the invention relates to the use of such peptide- based compounds used as targeting vectors that bind to receptors associated with angiogenesis, in particular the avb3 integrin receptor. Such contrast agents may thus be used for diagnosis of for example malignant diseases, heart diseases, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma. Moreover such compounds may also be used in therapeutic treatment of these diseases.
L'invention concerne de nouveaux composés à base de peptides et leur utilisation dans des traitements thérapeutiquement efficaces, ainsi que dans des techniques d'imagerie diagnostique. Plus spécialement, l'invention concerne l'utilisation de ces composés comme vecteurs de ciblage qui se lient à des récepteurs associés à l'angiogénèse, en particulier le récepteur de l'intégrine .alpha.v.beta.3. Ces agents de contraste peuvent ainsi être utilisés dans le diagnostique, par exemple, de maladies malignes, des maladies cardiaques, des maladies liées à une inflammation, l'arthrite rhumatoïde et le sarcome de Kaposi. Ces composés peuvent, en outre, être utilisés dans le traitement thérapeutique de ces maladies.
Amersham Health As
Fetherstonhaugh & Co.
Ge Healthcare As
LandOfFree
Peptide-based compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide-based compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-based compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1972961